0001567619-19-013015.txt : 20190607 0001567619-19-013015.hdr.sgml : 20190607 20190607113519 ACCESSION NUMBER: 0001567619-19-013015 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190607 DATE AS OF CHANGE: 20190607 EFFECTIVENESS DATE: 20190607 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STRAND THERAPEUTICS INC CENTRAL INDEX KEY: 0001778475 IRS NUMBER: 824027324 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-341413 FILM NUMBER: 19884644 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG 200, SUITE 001 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 309-360-9875 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG 200, SUITE 001 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001778475 STRAND THERAPEUTICS INC ONE KENDALL SQUARE BLDG 200, SUITE 001 CAMBRIDGE MA MASSACHUSETTS 02139 309-360-9875 DELAWARE None None Corporation true 2017 Jacob Becraft c/o Strand Therapeutics One Kendall Sq., Bldg 200, Ste. 001 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Promoter Mr. Becraft is the Vice-President and Treasurer of the Issuer. Tasuku Kitada c/o Strand Therapeutics One Kendall Sq., Bldg 200, Ste. 001 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Promoter Mr. Kitada is the President and Secretary of the Issuer. Jory Bell c/o Strand Therapeutics One Kendall Sq., Bldg 200, Ste. 001 Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2019-05-24 false true true Series Seed Preferred Stock false 0 5886624 5886624 0 false 11 0 0 0 false STRAND THERAPEUTICS INC /s/ Tasuku Kitada Tasuku Kitada President of the Issuer 2019-06-07